Hydrobromides
Medchemexpress LLC 1,4-PBIT (dihydrobromide) | 157254-60-9 | 98.0% | 444.25 g·mol⁻¹ | C12H20Br2N4S2 | 5 MG
1,4-PBIT (dihydrobromide) is a research-grade small-molecule inhibitor of nitric oxide synthases provided as the dihydrobromide salt (CAS 157254-60-9). Supplied in small-mass vials for biochemical and pharmacological studies, the compound is characterized by analytical documentation and high purity suitable for in vitro research.
- Potent inhibitor of iNOS, eNOS, and nNOS isoforms.
- High purity for reliable experimental results.
- Available in small-mass vials suitable for medicinal chemistry applications.
- Stable dihydrobromide salt form for consistent handling.
- Documented analytical data and certificate of analysis available.
Medchemexpress LLC CCT031374 hydrobromide | 1219184-91-4 | 98.1% | 434.33 | 10 MG
CCT031374 hydrobromide is a potent inhibitor of β-catenin/transcription factor (TCF) complex signaling. It inhibits TCF-dependent transcription of genes of the Wnt signaling pathway and exhibits antitumor activity.
- Potent inhibitor of β-catenin/TCF complex signaling
- Inhibits TCF-dependent transcription of Wnt signaling pathway genes
- Has antitumor activity
Medchemexpress LLC Scopolamine hydrobromide trihydrate | 6533-68-2 | MFCD00150066 | 99.86% | 438.31 | 50 MG
Scopolamine hydrobromide trihydrate, also known as Hyoscine hydrobromide trihydrate, is a potent muscarinic antagonist capable of crossing the blood-brain barrier. It competitively antagonizes 5-HT3 receptors with an IC50 of 2.09 μM. This compound has been observed to induce cognitive and memory deficits in animals. It is currently being investigated for its potential applications in the prevention of postoperative nausea and vomiting, motion sickness, and nervous system diseases.
- High-affinity muscarinic antagonist.
- Able to cross the blood-brain barrier.
- Competitively antagonizes 5-HT3 receptors.
- Used in research for preventing postoperative nausea and vomiting.
- Used in research for motion sickness.
- Used in research for nervous system diseases.
Medchemexpress LLC L-2,4-diaminobutyric acid hydrobromide | 73143-97-2 | MFCD07368664 | 98.0% | 199.05 g/mol | C4H11BrN2O2 | 500 MG
L-2,4-diaminobutyric acid hydrobromide (L-DABA hydrobromide) is a research chemical described as a weak GABA transaminase inhibitor (IC50 > 500 μM) and reported to exhibit antitumor activity in vitro and in vivo. It is supplied as the hydrobromide salt, CAS 73143-97-2, with molecular weight 199.05 g/mol and reported purity 98.0%.
- High purity: 98.0%.
- Reported activity: weak GABA transaminase inhibitor (IC50 > 500 μM).
- Demonstrated antitumor activity in vitro and in vivo.
- Provided as hydrobromide salt for research use.
- Available in 500 mg pack size.
Apexbio Technology LLC Homatropine Methylbromide 80-49-9 10mM (in 1mL DMSO)
Homatropine Methylbromide (CAS 80-49-9) is a small molecule antagonist of muscarinic acetylcholine receptors (AChRs) It inhibits muscarinic signaling by blocking receptor activity on endothelial and smooth muscle cells as demonstrated in WKY-E and SHR-E models with IC50 values of 162 5 nM and 170 3 nM respectively This compound is utilized in studies investigating cholinergic modulation of vascular tone and smooth muscle function offering a tool for dissecting the roles of muscarinic receptors in cardiovascular and autonomic research contexts
eMolecules 2403-33-0 | 2-BROMOPROPYLAMINE HBR | MFCD22055759 | 1g
AstaTech | 34-DIMETHOXY-2-METHYLBENZOIC ACID | 0.25g | 256638766 | 31432 | 95.000 | 5722-94-1 | MFCD09701444 | 196.202 | C10H12O4
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
Medchemexpress LLC Pyrithiamine hydrobromide | 534-64-5 | 96.6% | 25 MG
Pyrithiamine hydrobromide is a thiamine metabolic inhibitor supplied as a high-purity solid for laboratory research. It is used to study thiamine-dependent biochemical pathways and nervous system disease models.
- Thiamine metabolic inhibitor for biochemical research.
- Acts as a substrate for thiamine pyrophosphokinase.
- Purity 96.6% (manufacturer reported).
- Molecular formula C14H20Br2N4O and molecular weight 420.14 g·mol⁻¹.
- CAS number 534-64-5.
- Supplied as a 25 MG solid for laboratory use; not for human consumption.
Medchemexpress LLC Halofuginone (hydrobromide) | 64924-67-0 | 495.59 | 25 MG
Halofuginone hydrobromide, a Febrifugine derivative, is a competitive prolyl-tRNA synthetase inhibitor. It specifically inhibits type-I collagen synthesis and helps reduce osteoarthritis by inhibiting TGF-β activity. It also acts as a potent pulmonary vasodilator by activating Kv channels and blocking various Ca2+ channels. This compound exhibits a range of beneficial effects.
- Competitively inhibits prolyl-tRNA synthetase
- Inhibits type-I collagen synthesis
- Attenuates osteoarthritis by inhibiting TGF-β activity
- Potent pulmonary vasodilator
- Activates Kv channels and blocks Ca2+ channels
- Exhibits anti-malaria effects
- Provides anti-inflammatory effects
- Shows anti-cancer activity
- Offers anti-fibrosis effects
- Decreases NRF2 protein levels in tumors
eMolecules 62595-74-8 | 3-bromopiperidine-2,6-dione | Pharmablock | MFCD11053059 | 192.012 | C5H6BrNO2 | 97.000 | BrC1CCC(=O)NC1=O | 50g | 642185381
3-bromopiperidine-2,6-dione | Pharmablock | 62595-74-8 | MFCD11053059 | 192.012 | C5H6BrNO2 | 97.000 | BrC1CCC(=O)NC1=O | 50g | 642185381
Medchemexpress LLC Halofuginone (hydrobromide) | 64924-67-0 | 495.59 | 1 ML
Halofuginone hydrobromide (RU-19110 hydrobromide), a Febrifugine derivative, acts as a competitive prolyl-tRNA synthetase inhibitor with a Ki of 18.3 nM. It specifically inhibits type-I collagen synthesis and reduces osteoarthritis (OA) by inhibiting TGF-β activity. Additionally, it functions as a potent pulmonary vasodilator through the activation of Kv channels and the blocking of voltage-gated, receptor-operated, and store-operated Ca2+ channels.
- Competitive prolyl-tRNA synthetase inhibitor (Ki of 18.3 nM)
- Inhibits type-I collagen synthesis
- Reduces osteoarthritis (OA) by inhibiting TGF-β activity
- Potent pulmonary vasodilator through Kv channel activation
- Blocks voltage-gated, receptor-operated, and store-operated Ca2+ channels
- Exhibits anti-malaria, anti-inflammatory, anti-cancer, and anti-fibrosis effects